Receptor Surface Models. 1. Definition and Construction

Journal of Medicinal Chemistry

Volumn 38, Issue 12, 1995, Pages 2080-2090

  Hahn, Mathew ^a  

^a Molecular Simulations Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG RECEPTOR; LEVORPHANOL; MORPHINE; ONDANSETRON; PETHIDINE;

ARTICLE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; MOLECULAR INTERACTION; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

BINDING SITES; MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTORS, DRUG; SUPPORT, NON-U.S. GOV'T;

EID: 0029065636     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00012a007     Document Type: Article

References (37)

1. Doweyko, A. M. The Hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules. J. Med. Chem. 1988, 31, 1396-1406.
2. Wiese, M. The Hypothetical Active-Site Lattice. In 3D QSAR in Drug Design: Theory Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 80-116.
3. Kato, Y.; Itai, A.; Iitaka, Y. A novel method for superimposing molecules and receptor mapping. Tetrahedron 1987, 43, 5229-5236.
4. Kato, Y.; Inoue, A.; Yamada, M.; Tomioka, N.; Itai, A. Automatic superposition of drug molecules based on their common receptor site. J. Comput. Assisted Mol. Design 1992, 6, 475-486.
5. Srivastava, S.; Richardson, W. W.; Bradley, M. P.; Crippen, G. M. Three-Dimensional Receptor Modeling Using Distance Geometry and Voronoi Polyhedra. In 3D QSAR in Drug Design: Theory Methods and Applications’, Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 80-116.
6. Snyder, J. P.; Rao, S. N.; Koehler, K. F.; Vedani, A. Minireceptors and Pseudoreceptors. In 3D QSAR in Drug Design: Theory Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 336-354.
7. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
8. Cramer, R. D.; DePriest, S. A.; Patterson, D. E.; Hecht. The Developing practice of Comparative Molecular Field Analysis. In 3D QSAR in Drug Design: Theory Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 443-485.
9. Walters, D. E.; Hinds, R. M. Genetically Evolved Receptor Models: A Computational Approach to Construction of Receptor Models. J. Med. Chem. 1994, 37, 2527-2535.
10. Connolly, M. L. Analytical molecular surface calculation. J. App. Crystallogr. 1983, 16, 548-558.
11. Connolly, M. L. Sovlent-accessible surface of proteins and nucleic acid. Science 1983, 221, 709-713.
12. Purvis, G. D. On the use of isovalued surfaces to determine molecule shape and reaction pathways. J. Comput.-Aided Mol. Design 1991, 5, 55-80.
13. Klein, T. E.; Huang, C. C.; Pattersen, E. F.; Couch, G. S.; Ferrin, T. E.; Langridge, R. A real-time malleable surface. J. Mol. Graphics 1990, 8, 16-24.
14. Leicester, S. E.; Finney, J. L.; Bywater, R. P. Description of molecular surface shape using Fourier descriptors. J. Mol. Graphics 1988, 6, 104-108.
15. Hahn, M. A.; Rogers, D. Receptor surface models. 2. Application to Quantitative Structure Activity Relationship Studies. J. Med. Chem. 1995, 38, 2091-2102.
16. Kearsely, S. K.; Smith, G. M. An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlap. Tetrahedron Comput. Methodol. 1990, 3, 615-633.
17. Dammkoehler, R. A.; Karasak, S. F.; Berkely Shands, E. F.; Marshall, G. R. Constrained search of conformation hyperspace. J. Comput.-Aided Mol. Design 1989, 3, 3-21.
18. Perkins, T. D.; Deam, P. M. An exploration of a novel strategy for superimposing several flexible molecules. J. Comput.-Aided Mol. Design 1993, 7, 155-172.
19. Blaney, J. M.; Dixon, J. S. A good ligand is hard to find: Automatic docking methods. Perspect. Drug Disc. Design 1993, 1, 301-319.
20. Martin, Y. C.; Bures, M. G.; Danahar, E. A.; DeLazzar, J.; Lico, I.; Pavlik, P. A. A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists. J. Comput.-Aided Mol. Design 1993, 7, 83.
21. Hoffmann, R.; Langer, T. Use of the CATALYST program as a new alignment tool for 3D QSAR. In Proceedings of the 10th European Symposium on Structure-Activity Relationships: QSAR and Molecular Modeling; Prous Science Publishers: Barcelona, Spain, 1994.
22. Barnum, D.; Greene, J.; Smellie, A. Identification of Common Functional Configurations. J. Chem. Inf. Comput. Sci. In press.
23. Marshall, G. R. Binding Site Modeling of Unknown Receptors. In 3D QSAR in Drug Design: Theory Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 80-116.
24. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849-857.
25. Wyvill, G.; McPheeters, C.; Wyvill, B. Data Structures for Soft Objects. The Visual Computer 1986, 2, 227-234.
26. Lorensen, W. E.; Cline, H. E. Marching Cubes: A High Resolution 3-D Surface Construction Algorithm. Comput. Graphics (Proc. SIGGRAPH, 21) 1987, 4, 163-169.
27. Heiden, W.; Schlenkrich, M.; Brickmann, J. Triangulation algorithms for the representation of molecular surface properties. J. Comput.-Aided Mol. Design 1990, 4, 225-269.
28. Teschner, M.; Henn, C.; Vollhardt, H.; Reiling, S.; Brickmann, J. Texture Mapping: A new tool for molecular graphics. J. Mol. Graphics 1994, 12, 98-105.
29. Gasteiger, J.; Marsili, M. Tetrahedron 1980, 36, 3219.
30. Appelt, K. Crystal Structures of HIV-1 protease-inhibitor complexes. Perspect. Drug Disc. Design 1993, 1, 23-48.
31. Hopfinger, A. J.; Nakata, Y.; Max, N. Quantitative structure- activity relationship of anthracycline antitumor activity and cardiac toxicity based upon intercalation calculations. In Intermolecular Forces; Pullman, B., Ed.; Reidel: Dordrecht, 1981; p 431.
32. Hopfinger, A. J.; Kawakami, Y. QSAR analysis of a set of benzothiopyranoindazole anti-cancer analogs based on their DNA intercalation properties as determined by molecular dynamics simulation. Anti-Cancer Drug Design 1992, 7, 203-217.
33. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMM: A program for macromolecular Energy, Minimization, and Dynamics Calculations. J. Comput. Chem. 1983, 4, 187-217.
34. Mayo, S. L.; Olafson, B. D.; Goddard, W. A. DREIDING: A generic force field for molecular simulations. J. Phys. Chem. 1990, 94, 8897-8909.
35. Davies, K. E.; Murall, N. W. How accurate does a force field need to be? Comput. Chem. 1989, 13, 149-156.
36. Halgren, T. A. Merck Molecular Force Field: I-IV. J. Comput. Chem. Submitted.
37. Weiner, J.; Kollman, P. A.; Nguyen, T.; Case, A. An all atom force field for simulations of proteins and nucleic acids. J. Comput. Chem. 1986, 7, 230-252.